The News Of Tomorrow, Today
The News Of Tomorrow, Today
antibodies
When President Trump was diagnosed with COVID-19, one of the cutting-edge experimental therapies he received was a mixture of monoclonal antibodies. But now a vaccine may soon be available. So are other therapies necessary or valuable? And what exactly is a monoclonal antibody? Over the past few months, the public…
Pharmaceutical company Eli Lilly is the latest to temporarily halt one of its covid-19 clinical trials. The Phase III trial, involving an experimental antibody treatment for patients with the viral illness and sponsored by the federal government, was paused due to a “potential safety concern,” according to government emails obtained…
A new study from Iceland provides reassurance that our antibodies to the coronavirus that causes covid-19 can last at least four months — assuming that we produce them in the first place.
There are no more articles to be viewed
Haven't registered?
Sign up here
Lost your password?
Click here to reset
Back to Login?
Click here
Subscribe to our newsletter!
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.